e-learning
resources
Vienna 2003
Sunday 28.09.2003
Epidemiology, therapy and outcome of infections in the ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, M. H. Kollef (Alexandria, Egypt; Saint Louis, United States Of America)
Source:
Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Session:
Epidemiology, therapy and outcome of infections in the ICU
Session type:
Oral Presentation
Number:
231
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, M. H. Kollef (Alexandria, Egypt; Saint Louis, United States Of America). The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Eur Respir J 2003; 22: Suppl. 45, 231
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Related content which might interest you:
Does the management and outcome of community-acquired pneumonia differ depending on the route of admission to hospital?
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 549s
Year: 2004
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care
Source: Eur Respir J 2006; 27: 1223-1228
Year: 2006
Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Comparison of invitro antimicrobial susceptibility tests of patients admitted in a tertiary respiratory center intensive care unit with their clinical symptoms related to ventilator associated pneumonia (in vivo results)
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
The impact of a delay in intensive care unit admission for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 826-833
Year: 2010
Previous antibacterial therapy and drug-resistance among pathogens in ICU patients with nosocomial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 405s
Year: 2001
The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Antibiotic use
Source: Annual Congress 2005 - Protocols in the critically ill patient
Year: 2005
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Source: Eur Respir J 2006; 27: 158-164
Year: 2006
Epidemiology, clinical features and risk factors for adverse outcome of patients with pulmonary tuberculosis (TB) in an intensive care unit (ICU)
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003
Prognosis factors influencing three-month respiratory outcomes in intensive care unit survivors after COVID-19 pneumonia
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Differences in clinical courses of nosocomial pneumonia between patients of surgical and therapeutic departments
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006
Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007
Etiological organisms from patients with hospital acquired pneumonia and its mortality in the respiratory intensive care unit
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept